Research Article
[Retracted] Additional Benefits Conferred by Endoscopic Sclerotherapy to Liver Cirrhosis Patients Receiving Endoscopic Variceal Ligation
Table 3
The hemostasis rate within 72 hours, incidence rate of complications, and short-term rebleeding rate among three groups after treatment.
| | Group | Hemostasis rate (n (%)) | Complications (n (%)) | Short-term rebleeding (n (%)) |
| | Ligation group (n = 45) | 38 (84.44) | 5 (11.11) | 11 (24.44) | | Sclerotherapy group (n = 45) | 36 (80.00) | 13 (28.89) | 9 (20.00) | | Combined group (n = 45) | 45 (100.00) | 5 (11.11) | 4 (8.89) | | χ2/P (ligation vs. sclerotherapy) | 0.304/0.581 | 4.444/0.035 | 0.257/0.612 | | χ2/P (ligation vs. combined) | 7.590/0.006 | 0.000/1.000 | 3.920/0.048 | | χ2/P (sclerotherapy vs. combined) | 10.000/0.002 | 4.444/0.035 | 2.248/0.134 |
|
|
